Physician profile
Ajith G Kumar
NPI 1386611267
$4,288.41
in general payments reported to CMS, 2019-2025
39 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $893 · 2020: $189 · 2021: $700 · 2022: $847 · 2023: $679 · 2024: $693 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,620 · Education: $39.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,620.06 |
| Education | $39.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $481.61 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $433.56 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $429.73 | 2019-2024 | Brilinta |
| Amgen INC. | $418.38 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $373.06 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $285.55 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $264.38 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $248.65 | 2021-2024 | Verquvo |
| Boston Scientific Corporation | $163.51 | 2019-2024 | Watchman Flx |
| Roche Diagnostics Corporation | $117.97 | 2022 | |
| Medtronic Vascular, INC. | $114.21 | 2019-2020 | |
| Glaxosmithkline, LLC. | $102.88 | 2024-2025 | Shingrix |
| E.R. Squibb & Sons, L.L.C. | $87.26 | 2019-2024 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $80.58 | 2021-2025 | Nexletol |
| Regeneron Healthcare Solutions, INC. | $73.56 | 2019-2023 | Evkeeza |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $58.64 | 2021-2022 | |
| Angiodynamics, INC. | $52.78 | 2023 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $50.82 | 2021-2022 | |
| Tactile Systems Technology INC | $36.03 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Scpharmaceuticals INC. | $34.17 | 2025 | |
| Amarin Pharma, INC. | $31.37 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $31.28 | 2019 | |
| Lantheus Medical Imaging, INC. | $27.08 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $24.89 | 2022 | |
| Atricure, INC. | $23.80 | 2024 | |
| Heartflow, INC. | $23.63 | 2024 | |
| Cook Medical LLC | $22.04 | 2019 | |
| Nuwellis, INC. | $20.81 | 2019 | |
| Cardiovascular Systems INC. | $19.16 | 2019-2021 | |
| Cvrx, INC. | $19.13 | 2022 | |
| Medicomp INC | $18.50 | 2019 | |
| Cardinal Health 200 LLC | $18.10 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.14 | 2022 | |
| Chiesi USA, INC. | $16.63 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $15.43 | 2023 | Inpefa |
| Bridgebio Pharma, INC. | $14.35 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $14.22 | 2023 | Assure Wcd |
| Ekos Corporation | $12.42 | 2019 | |
| Abbott Laboratories | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajith Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.